Danish Pharmacovigilance Update, September 2014
07 October 2014
The September issue of Danish Pharmacovigilance Update.
News from the EU
- Denosumab (Prolia and Xgeva) and risk of osteonecrosis of the jaw and hypocalcaemia, page 2
- Interferon beta and risk of serious adverse reactions, page 4
News from the DHMA
- Scopoderm® transdermal patches and visual disturbances, page 5
- Childhood vaccinations and reported suspected adverse reactions in Q2 of 2014, page 6
Short news
- Most recent Direct Healthcare Professional Communications (DHPCs), page 13